BioCentury | Jul 24, 2020
Politics, Policy & Law

Moderna says commercial path remains clear despite unfavorable patent ruling

...viral target-specific licenses to four patents covering Arbutus’ LNP technology through a sublicensing deal with Acuitas Therapeutics Inc. Elizabeth...
Items per page:
1 - 1 of 1
BioCentury | Jul 24, 2020
Politics, Policy & Law

Moderna says commercial path remains clear despite unfavorable patent ruling

...viral target-specific licenses to four patents covering Arbutus’ LNP technology through a sublicensing deal with Acuitas Therapeutics Inc. Elizabeth...
Items per page:
1 - 1 of 1